High-throughput combination assay for studying biofilm formation of uropathogenic Escherichia coli
Archives of Microbiology · 2024-08 · 206 (8)
DOI: 10.1007/s00203-024-04029-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Microbiology, online erschienen am 05.07.2024. Verfasst von M Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Helsinki, FI-00014, Finland. Hauptthemen laut MEDLINE: Biofilms, Uropathogenic Escherichia coli, High-Throughput Screening Assays, Xanthenes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Helsinki.
Abstract (Originalsprache)
Uropathogenic Escherichia coli , the most common cause for urinary tract infections, forms biofilm enhancing its antibiotic resistance. To assess the effects of compounds on biofilm formation of uropathogenic Escherichia coli UMN026 strain, a high-throughput combination assay using resazurin followed by crystal violet staining was optimized for 384-well microplate. Optimized assay parameters included, for example, resazurin and crystal violet concentrations, and incubation time for readouts. For the assay validation, quality parameters Z′ factor, coefficient of variation, signal-to-noise, and signal-to-background were calculated. Microplate uniformity, signal variability, edge well effects, and fold shift were also assessed. Finally, a screening with known antibacterial compounds was conducted to evaluate the assay performance. The best conditions found were achieved by using 12 µg/mL resazurin for 150 min and 0.023% crystal violet. This assay was able to detect compounds displaying antibiofilm activity against UMN026 strain at sub-inhibitory concentrations, in terms of metabolic activity and/or biomass. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Helsinki, FI-00014, Finland.
- Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Helsinki, FI-00014, Finland. paivi.tammela@helsinki.fi.
Förderung
- University of Helsinki
Zitieren
APA
Li, M., Cruz, C. D., Ilina, P., & Tammela, P. (2024). High-throughput combination assay for studying biofilm formation of uropathogenic Escherichia coli. Archives of Microbiology, 206(8). https://doi.org/10.1007/s00203-024-04029-w
Vancouver
Li M, Cruz CD, Ilina P, Tammela P. High-throughput combination assay for studying biofilm formation of uropathogenic Escherichia coli. Archives of Microbiology. 2024;206(8). doi:10.1007/s00203-024-04029-w
BibTeX
@article{Li2024,
author = {Li, M and Cruz, C D and Ilina, P and Tammela, P},
title = {High-throughput combination assay for studying biofilm formation of uropathogenic Escherichia coli},
journal = {Archives of Microbiology},
year = {2024},
volume = {206},
number = {8},
doi = {10.1007/s00203-024-04029-w}
}
EUVIMED